LIA Diagnostics

Philadelphia, United States Founded: 2015 • Age: 11 yrs
Disposable paper pregnancy test kits

About LIA Diagnostics

LIA Diagnostics is a Healthcare company based in Philadelphia (United States) founded in 2015. Disposable paper pregnancy test kits. LIA Diagnostics has raised $4.22 million across 4 funding rounds from investors including The Pink Ceiling, Ben Franklin Technology Partners and Robin Hood Ventures. Its focus areas include Life Sciences, Women Health, In Vitro Diagnostic Tests and Fertility. Its legal entity is LIA Diagnostics Inc. Its competitors include Celmatix, Confer Health and adyn; 3 of its 3 listed competitors have raised funding.

Company details

LIA Diagnostics develops paper pregnancy tests that are foldable and disposable. This addresses the challenges surrounding privacy, usability, and sustainability in current at-home diagnostics.It claims that the product is scheduled to go on sale in 2016-17. LIA Diagnostics won the Innovative Idea Competition award at Temple university in 2015

  • Headquarters Philadelphia, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website liadiagnostics.com
  • Social LinkedIn X Facebook
  • Legal Name Lia Diagnostics Inc.
Key Metrics
  • Total Equity Funding
    $4.22M (USD)

    in 4 rounds

  • Latest Funding Round
    $2.6M (USD), Seed

    Nov 2018

  • Investors

Funding Insights of LIA Diagnostics

LIA Diagnostics has successfully raised a total of $4.22M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.6 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.22M
  • Total Rounds 4
  • Last Round Seed β€” $2.6M
  • Investors Count 4

All 4 funding rounds of LIA Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2018$2.6MSeed–The Pink Ceiling
May 2017$950,000Seed––
–
Nov 2015$670,000Seed––
–
Oct 2015Seed––
–
Valuation history

4 investors in total: 4 institutional.

Investors in LIA Diagnostics

LIA Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include The Pink Ceiling, Ben Franklin Technology Partners and Robin Hood Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Technology ecosystem growth is supported in Southeastern Pennsylvania.
sep.benfranklin.orgPhiladelphia, United States
Early-stage investments are made in high-growth startups by this group.
1999robinhoodventures.comPhiladelphia, United States
Startup accelerator
dreamit.comNew York, United States
The Pink Ceiling is focused on investing in women-led healthcare innovations.
thepinkceiling.com
Premium access

Investor details for LIA Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of LIA Diagnostics

3 dated milestones of LIA Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded LIA Diagnostics is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Seed, of $2.6M.

Competitors of LIA Diagnostics

LIA Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Celmatix, Confer Health and adyn.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
celmatix.com2009New York, United States$24.89M27
Fertility decisions are optimized using data analytics and genomics.
confer.health2015Boston, United States$9.5M
Clinical-grade diagnostic tests for home use are developed.
adyn.com2019Seattle, United States$2.65M
Provider of DNA and hormone analysis based birth control optimization kits
Premium access

Detailed competitors of LIA Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Women's Health & Fertility

3 companies that operate in the same segment as LIA Diagnostics (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of cell-free DNA testing for oncology, women’s health, and organ health
2004Redwood City, California, United StatesUSD 152.1 MUSD 2.31 B4,430
Therapeutics for women's healthcare are developed and offered.
1997Princeton, New Jersey, United StatesUSD 123.06 MUSD 19.59 M
Provider of cell-free cancer liquid biopsy test
2015San Francisco, California, United StatesUSD 388.62 M861
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lia Diagnostics

Premium access

Complete news archive for LIA Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LIA Diagnostics

LIA Diagnostics was founded in 2015.

LIA Diagnostics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

LIA Diagnostics is a funded company, having raised a total of $4.22M across 4 funding rounds to date.

LIA Diagnostics develops paper pregnancy tests that are foldable and disposable. This addresses the challenges surrounding privacy, usability, and sustainability in current at-home diagnostics.It claims that the product is scheduled to go on sale in 2016-17. LIA Diagnostics won the Innovative Idea Competition award at Temple university in 2015.

LIA Diagnostics's top competitors include Celmatix, adyn and Confer Health.

LIA Diagnostics has 4 investors. Key investors include The Pink Ceiling, Ben Franklin Technology Partners, Robin Hood Ventures, and Dreamit.

LIA Diagnostics operates through Lia Diagnostics Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available